Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Inventory (2022 - 2025)

Core Laboratories (CLB) has 4 years of Inventory data on record, last reported at $58.2 million in Q3 2025.

  • For Q3 2025, Inventory fell 11.07% year-over-year to $58.2 million; the TTM value through Sep 2025 reached $58.2 million, down 11.07%, while the annual FY2024 figure was $59.4 million, 17.15% down from the prior year.
  • Inventory reached $58.2 million in Q3 2025 per CLB's latest filing, down from $59.8 million in the prior quarter.
  • Across five years, Inventory topped out at $75.1 million in Q3 2023 and bottomed at $58.2 million in Q3 2025.
  • Average Inventory over 4 years is $65.6 million, with a median of $65.5 million recorded in 2024.
  • Peak YoY movement for Inventory: grew 18.62% in 2023, then fell 17.15% in 2024.
  • A 4-year view of Inventory shows it stood at $60.4 million in 2022, then rose by 18.62% to $71.7 million in 2023, then fell by 17.15% to $59.4 million in 2024, then fell by 1.95% to $58.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $58.2 million in Q3 2025, $59.8 million in Q2 2025, and $59.0 million in Q1 2025.